SHENZHEN, China, Feb. 18 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Jie Liu, Mindray’s executive vice president of international sales and marketing, and Mr. Sheng Ma, Mindray’s president of international sales and marketing for ultrasound imaging systems, will attend the 2008 European Congress of Radiology to be held March 7 to 11, in Vienna, Austria.
“Our products continue to receive strong brand loyalty, particularly in European markets and we are delighted to showcase our ultrasound imaging systems at such a prominent international event,” said Mr. Xu Hang, Mindray’s chairman and co-chief executive officer. “Specifically, we are excited to display the M5 and DC-3 that both hold significant market potential. Our high-quality, competitively priced products are the result of our disciplined investment in R&D and ability to tailor products by price and functionality for markets around the world.”
The company will exhibit both its new M5, a portable color Doppler diagnostic ultrasound system released in December 2007, and DC-3, a color Doppler diagnostic ultrasound system which will be launched domestically upon receiving SFDA approval and internationally upon receiving CE Mark, which is expected to occur during the first quarter of 2008.
“The M5 is ideally suited for both new and traditional markets such as radiology and OB/GYN as well as Point-of-Care-Testing (“POCT”) centers such as emergency and operating rooms, intensive care units and general practice offices,” said Mr. Li Xiting, Mindray’s president and co-chief executive officer. “The DC-3 is customized for hospitals and clinics looking to replace B&W diagnostic ultrasound systems.”
The company will also display its established DC-6, DC-6E, DP-6600, DP-7700, DP-8800 plus, DP-9900 plus, DP-2200, DP-3300, DP-6600 Vet products in Expo E at booth number 540.
Since 2003, Mindray has exported its diagnostic ultrasound systems to more than 140 countries. These systems are employed in medical fields such as urology, gynecology, obstetrics, abdomen, small parts and cardiology.
About Mindray
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Boston, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about new product releases and regulatory approvals are forward- looking statements. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public documents filed with the Securities and Exchange Commission. For a discussion of some of the risks and important factors that could affect Mindray’s actual results and financial condition, see “Risk Factors” in Part I, Item 3D of Mindray’s Annual Report on Form 20-F for the fiscal year ended December 31, 2006 and “Operating and Financial Review and Prospects” in Part I, Item 5 of Mindray’s Annual Report on Form 20-F for the fiscal year ended December 31, 2006. Mindray does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of February 18, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.
IR@Mindray.comJustin.Knapp@Ogilvy.com
CONTACT: In China, Investor Relations of Mindray Medical International
Limited, +86-755-2658-2518, or IR@Mindray.com; or Justin Knapp of Ogilvy
Public Relations Worldwide, Beijing, +86-10-8520-6556, or
Justin.Knapp@Ogilvy.com; In the United States, Jeremy Bridgman of Ogilvy
Public Relations Worldwide, New York, +1-212-880-5363, both for Mindray
Web site: http://www.mindray.com/
